{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:43:43Z","timestamp":1790682223582,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.eclinm.2021.101225","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T17:59:09Z","timestamp":1638208749000},"page":"101225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivo"],"prefix":"10.1016","volume":"42","author":[{"given":"Nathan W","family":"Cummins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick G","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Garcia-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashton","family":"Krogman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaji","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3089-0601","authenticated-orcid":false,"given":"Yury V","family":"Kuzmichev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M","family":"Laird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Landay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Lichterfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Martinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8050-115X","authenticated-orcid":false,"given":"Mark","family":"Maynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sekar","family":"Natesampillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Rajkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelizaveta","family":"Rassadkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen D.","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina G","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey A","family":"Rizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krupa","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron J","family":"Tande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0773-6569","authenticated-orcid":false,"given":"Elizabeth R","family":"Wonderlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A","family":"Whitaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4850-7065","authenticated-orcid":false,"given":"John","family":"Zeuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D","family":"Badley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.eclinm.2021.101225_bib0001","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1097\/QAD.0b013e328340a239","article-title":"Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication","volume":"24","author":"Chun","year":"2010","journal-title":"Aids"},{"issue":"5341","key":"10.1016\/j.eclinm.2021.101225_bib0002","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science"},{"issue":"5341","key":"10.1016\/j.eclinm.2021.101225_bib0003","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1126\/science.278.5341.1291","article-title":"Recovery of replication-competent HIV despite prolonged suppression of plasma viremia","volume":"278","author":"Wong","year":"1997","journal-title":"Science"},{"issue":"24","key":"10.1016\/j.eclinm.2021.101225_bib0004","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1073\/pnas.94.24.13193","article-title":"Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy","volume":"94","author":"Chun","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.eclinm.2021.101225_bib0005","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nri3262","article-title":"Towards an HIV cure: a global scientific strategy","volume":"12","author":"ASSWGoHIVC","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"7408","key":"10.1016\/j.eclinm.2021.101225_bib0006","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/487439a","article-title":"HIV: Shock and kill","volume":"487","author":"Deeks","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.eclinm.2021.101225_bib0007","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.chom.2017.12.004","article-title":"Getting the \"Kill\" into \"Shock and Kill\": Strategies to Eliminate Latent HIV","volume":"23","author":"Kim","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"7408","key":"10.1016\/j.eclinm.2021.101225_bib0008","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature11286","article-title":"Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy","volume":"487","author":"Archin","year":"2012","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.eclinm.2021.101225_bib0009","doi-asserted-by":"crossref","first-page":"e520","DOI":"10.1016\/S2352-3018(15)00226-X","article-title":"Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study","volume":"2","author":"Elliott","year":"2015","journal-title":"Lancet HIV"},{"issue":"10","key":"10.1016\/j.eclinm.2021.101225_bib0010","article-title":"Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy","volume":"10","author":"Elliott","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.eclinm.2021.101225_bib0011","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fmicb.2011.00161","article-title":"Viral takeover of the host ubiquitin system","volume":"2","author":"Gustin","year":"2011","journal-title":"Front Microbiol"},{"issue":"12","key":"10.1016\/j.eclinm.2021.101225_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20122984","article-title":"Role of the Ubiquitin Proteasome System (UPS) in the HIV-1 Life Cycle","volume":"20","author":"Rojas","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.eclinm.2021.101225_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007498","article-title":"Reiterative Enrichment and Authentication of CRISPRi Targets (REACT) identifies the proteasome as a key contributor to HIV-1 latency","volume":"15","author":"Li","year":"2019","journal-title":"PLoS Pathog"},{"issue":"13","key":"10.1016\/j.eclinm.2021.101225_bib0014","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00037-18","article-title":"HIV Protease-Generated Casp8p41, When Bound and Inactivated by Bcl2, Is Degraded by the Proteasome","volume":"92","author":"Natesampillai","year":"2018","journal-title":"J Virol"},{"issue":"50","key":"10.1016\/j.eclinm.2021.101225_bib0015","doi-asserted-by":"crossref","first-page":"26177","DOI":"10.1074\/jbc.M116.743906","article-title":"Heat Shock Protein 90 Facilitates Latent HIV Reactivation through Maintaining the Function of Positive Transcriptional Elongation Factor b (p-TEFb) under Proteasome Inhibition","volume":"291","author":"Pan","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.eclinm.2021.101225_bib0016","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2052-8426-2-20","article-title":"Making sense of how HIV kills infected CD4 T cells: implications for HIV cure","volume":"2","author":"Cummins","year":"2014","journal-title":"Mol Cell Ther"},{"issue":"11","key":"10.1016\/j.eclinm.2021.101225_bib0017","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/sj.cdd.4401094","article-title":"HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation","volume":"9","author":"Nie","year":"2002","journal-title":"Cell Death Differ"},{"issue":"7","key":"10.1016\/j.eclinm.2021.101225_bib0018","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1083\/jcb.201405051","article-title":"Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activation","volume":"206","author":"Sainski","year":"2014","journal-title":"J Cell Biol"},{"issue":"8","key":"10.1016\/j.eclinm.2021.101225_bib0019","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1128\/JVI.03179-15","article-title":"Prime, Shock, and Kill: Priming CD4 T Cells from HIV Patients with a BCL-2 Antagonist before HIV Reactivation Reduces HIV Reservoir Size","volume":"90","author":"Cummins","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.eclinm.2021.101225_bib0020","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00138-21","article-title":"The combination of venetoclax and ixazomib selectively and efficiently kills HIV infected cell lines, but has unacceptable toxicity in primary cell models","author":"Alto","year":"2021","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.eclinm.2021.101225_bib0021","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ccr.2013.02.017","article-title":"Control of autophagic cell death by caspase-10 in multiple myeloma","volume":"23","author":"Lamy","year":"2013","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.eclinm.2021.101225_bib0022","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1128\/JVI.74.11.5373-5376.2000","article-title":"Ubiquitination of the human immunodeficiency virus type 1 env glycoprotein","volume":"74","author":"Bultmann","year":"2000","journal-title":"J Virol"},{"issue":"24","key":"10.1016\/j.eclinm.2021.101225_bib0023","doi-asserted-by":"crossref","first-page":"13057","DOI":"10.1073\/pnas.97.24.13057","article-title":"Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2","volume":"97","author":"Schubert","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.eclinm.2021.101225_bib0024","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1742-4690-10-120","article-title":"Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication","volume":"10","author":"Miller","year":"2013","journal-title":"Retrovirology"},{"issue":"27","key":"10.1016\/j.eclinm.2021.101225_bib0025","doi-asserted-by":"crossref","first-page":"15763","DOI":"10.1073\/pnas.1916290117","article-title":"HSF1 inhibition attenuates HIV-1 latency reversal mediated by several candidate LRAs In Vitro and Ex Vivo","volume":"117","author":"Timmons","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.eclinm.2021.101225_bib0026","doi-asserted-by":"crossref","first-page":"e55943","DOI":"10.1371\/journal.pone.0055943","article-title":"Highly precise measurement of HIV DNA by droplet digital PCR","volume":"8","author":"Strain","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.eclinm.2021.101225_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008074","article-title":"Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals","volume":"15","author":"Wonderlich","year":"2019","journal-title":"PLoS Pathog"},{"issue":"4","key":"10.1016\/j.eclinm.2021.101225_bib0028","doi-asserted-by":"crossref","first-page":"ofv123","DOI":"10.1093\/ofid\/ofv123","article-title":"Designing and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1","volume":"2","author":"Rosenbloom","year":"2015","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"10.1016\/j.eclinm.2021.101225_bib0029","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1172\/JCI93289","article-title":"Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4+ T cells","volume":"127","author":"Lee","year":"2017","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.eclinm.2021.101225_bib0030","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1038\/s41467-019-10659-2","article-title":"HIV-1 DNA sequence diversity and evolution during acute subtype C infection","volume":"10","author":"Lee","year":"2019","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.eclinm.2021.101225_bib0031","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.celrep.2017.09.081","article-title":"Identification of Genetically Intact HIV-1 Proviruses in Specific CD4(+) T Cells from Effectively Treated Participants","volume":"21","author":"Hiener","year":"2017","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.eclinm.2021.101225_bib0032","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41467-019-08431-7","article-title":"Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion","volume":"10","author":"Pinzone","year":"2019","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.eclinm.2021.101225_bib0033","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/bioinformatics\/16.4.400","article-title":"Detecting hypermutations in viral sequences with an emphasis on G \u2013>A hypermutation","volume":"16","author":"Rose","year":"2000","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.eclinm.2021.101225_bib0034","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/nar\/gkh340","article-title":"MUSCLE: multiple sequence alignment with high accuracy and high throughput","volume":"32","author":"Edgar","year":"2004","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.eclinm.2021.101225_bib0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/infdis\/jiaa532","article-title":"Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy","volume":"223","author":"Gandhi","year":"2021","journal-title":"J Infect Dis"},{"issue":"15","key":"10.1016\/j.eclinm.2021.101225_bib0036","doi-asserted-by":"crossref","first-page":"8869","DOI":"10.1073\/pnas.95.15.8869","article-title":"Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection","volume":"95","author":"Chun","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5255","key":"10.1016\/j.eclinm.2021.101225_bib0037","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1126\/science.271.5255.1582","article-title":"HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time","volume":"271","author":"Perelson","year":"1996","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.eclinm.2021.101225_bib0038","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells","volume":"9","author":"Siliciano","year":"2003","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.eclinm.2021.101225_bib0039","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.chom.2020.03.014","article-title":"The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies","volume":"27","author":"Cohn","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"10","key":"10.1016\/j.eclinm.2021.101225_bib0040","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1016\/S2352-3018(16)30055-8","article-title":"Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B\/2A trial","volume":"3","author":"Leth","year":"2016","journal-title":"Lancet HIV"},{"issue":"9","key":"10.1016\/j.eclinm.2021.101225_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005142","article-title":"The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo","volume":"11","author":"Sogaard","year":"2015","journal-title":"PLoS Pathog"},{"issue":"17","key":"10.1016\/j.eclinm.2021.101225_bib0042","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1080\/14656566.2018.1528229","article-title":"Ixazomib for the treatment of multiple myeloma","volume":"19","author":"Richardson","year":"2018","journal-title":"Expert Opin Pharmacother"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258953702100506X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258953702100506X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:08:39Z","timestamp":1762888119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258953702100506X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":42,"alternative-id":["S258953702100506X"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2021.101225","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivo","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2021.101225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101225"}}